Status: current, Defined. Date: 31-Aug 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2670551000168116 | Zinc Magnesium Performance (Bioglan) (magnesium aspartate tetrahydrate 150 mg + magnesium oxide heavy 70 mg + pyridoxine hydrochloride 4.25 mg + zinc amino acid chelate 50 mg) capsule, 90 capsules, jar (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2670561000168119 | Zinc Magnesium Performance (Bioglan) capsule, 90, jar | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Zinc Magnesium Performance (Bioglan) capsule, 90, jar | Is a | Zinc Magnesium Performance (Bioglan) capsule, 90 | true | Inferred relationship | Some | ||
| Zinc Magnesium Performance (Bioglan) capsule, 90, jar | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Zinc Magnesium Performance (Bioglan) capsule, 90, jar | has TPUU | Zinc Magnesium Performance (Bioglan) (magnesium aspartate tetrahydrate 150 mg + magnesium oxide heavy 70 mg + pyridoxine hydrochloride 4.25 mg + zinc amino acid chelate 50 mg) capsule (trade product unit of use) | true | Inferred relationship | Some | 1 | |
| Zinc Magnesium Performance (Bioglan) capsule, 90, jar | has container type | jar | true | Inferred relationship | Some | ||
| Zinc Magnesium Performance (Bioglan) capsule, 90, jar | has TP | Zinc Magnesium Performance (Bioglan) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR